ConductScience.org, home

Trial · NCT02299414

Outcomes33

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYComposite Adverse Perinatal OutcomeUp to 2 weeks postpartum for preeclampsia or 90 days for neonatal deathParticipantsCOUNT_OF_PARTICIPANTS
PRIMARYSmall for Gestational Age (Safety)Until deliveryAnalysis is restricted to 2270 (1146 in the Treatment Group and 1124 in the Standard Group) who were delivered and who had complete assessments during delivery.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYComposite of Maternal Death or Severe Cardiovascular MorbidityUp to 6 weeks (4-12 weeks) after deliveryParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYSevere Maternal Hypertension + Components of the Primary Composite EndpointUp to 2 weeks postpartum or 90 days for neonatal deathParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPreterm Birth and Indicated Preterm Birth (<37 Weeks)Until deliveryParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYComposite of Severe Neonatal MorbiditiesUp to 90 days post deliveryParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYAdherence to Treatment After Delivery6 weeks (4-12 weeks) after deliveryAnalysis is restricted to 706 in Treatment Group and 479 in Standard Group who had complete antihypertensive therapy assessments at the follow-up study visit.ParticipantsCOUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIEDSuperimposed PreeclampsiaUp to 2 weeks after deliveryParticipantsCOUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIEDSuperimposed Gestational HypertensionEnrollment (between 6 and 18 weeks gestation) to deliveryParticipantsCOUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIEDSevere HypertensionUp to 6 weeks (4-12 weeks) after deliveryParticipantsCOUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIEDCesarean DeliveryUntil deliveryParticipantsCOUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIEDBlood TransfusionUp to 6 weeksParticipantsCOUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIEDNICU AdmissionUp to 6 weeks (4-12 weeks) after deliveryParticipantsCOUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIEDLow Birth WeightAt birthParticipantsCOUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIEDPonderal IndexAt birthdata incomplete for 71 in the Treated Group and 83 in the Standard Groupg/cm^3MEAN
OTHER_PRE_SPECIFIEDHead CircumferenceAt birthdata incomplete for 84 in the Treated Group and 97 in the Standard GroupcmMEAN
OTHER_PRE_SPECIFIEDPlacental WeightAt deliverydata incomplete for 549 in the Treated Group and 562 in the Standard GroupgMEAN
OTHER_PRE_SPECIFIEDHypoglycemiaFrom delivery to hospital discharge (2 - 3 days after delivery)ParticipantsCOUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIEDBradycardiaFrom delivery to hospital discharge (2 - 3 days after delivery)ParticipantsCOUNT_OF_PARTICIPANTS
OTHER_PRE_SPECIFIEDHypotensionFrom delivery to hospital discharge (2 - 3 days after delivery)ParticipantsCOUNT_OF_PARTICIPANTS

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02299414/outcomes